Troymister,
I see this investment as nearly 100% derisked at this point in time and see this opportunity as a pearl of great price. I bought most of my position near the first bottom and then the double bottom which , as you may know, I believe was set quickly this year by market makers. This does not mean no fluctuations in price until the news we all (or almost all) want to hear comes. I’ve been invested in biotechs more than 20 years and have never seen so much cumulative evidence that a company has not only a winner or blockbuster but a true breakthrough platform and has been so beaten down by lack of institutional support. Good news from NWBO on the heals of any Covid vaccine positive effect on the market may bring a staggering amount of interest because this is a platform technology which is ready to be advanced quickly once validated then approved. Typically buyouts come after approval but a partnership can come any time. I hear exwannabe has the best popcorn but he hasn’t invited us over yet. Best wishes.
News 
Market Data 
Discover 
